"Currently at Cleveland Clinic, our team is doing a clinical trial testing cancer vaccine in high-risk breast cancer," he says. Highlighting the role of cutting-edge technologies, he says computers using Artificial Intelligence (AI) can recognize variations in pattern from normal to abnormal in the biopsy, much more accurate than the human eye.